Skip to content

Member News Update from Lab Data Solutions LLC

Date: March 14, 2026

This news piece has been submitted by Lab Data Solutions LLC

We’re Attending US Summit 2026!

Lab Data Solutions LLC is pleased to announce that we will be attending the ACDM US Summit 2026, taking place May 18–19, 2026, in Princeton, New Jersey. Hosted by Genmab, this inaugural Summit marks an important milestone for the clinical data management community—and for us, it represents our first public appearance as a company.

The ACDM US Summit brings together leading voices in Clinical Data Management and the broader clinical research ecosystem to advance discussion, collaboration, and shared learning. Designed as a forum for both scientific and practical exchange, the Summit focuses on strengthening how data management supports trust, innovation, and impact across clinical research.

Under the theme “Clinical Data Management at the Heart: Driving Trust, Innovation, and Impact,” the programme includes thought‑leadership sessions, real‑world case discussions, and meaningful networking opportunities. The event will begin with a networking evening on May 18, followed by a full day of focused sessions and discussions on May 19.

As a company dedicated to supporting high‑quality lab data and reliable data review processes, Lab Data Solutions LLC values opportunities to engage directly with peers, sponsors, CROs, and data professionals who share a commitment to data integrity and operational excellence. The Summit’s emphasis on collaboration and inclusivity—welcoming participants from across the global ACDM community—aligns closely with our own approach to clinical data work.

We look forward to learning from industry leaders, contributing to conversations shaping the future of clinical data management, and building connections within the clinical research community. If you will be attending the ACDM US Summit 2026, we would welcome the opportunity to connect and exchange perspectives.

 


 

Explore More News

Welcome Debiopharm as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Debiopharm as a . . .

Read More

HMA/EMA joint Big Data Steering Group: Big Data Workplan 2023-2025

The joint HMA-EMA Big Data Steering Group (BDSG) have released their latest workplan, . . .

Read More

ACT EU PA04 – Multi-stakeholder Workshop on ICH E6 R3

As part of the Accelerating Clinical Trials in the EU (ACT EU) multi-annual workplan . . .

Read More

European Medicine’s Agency – Reflection paper on the use of artificial intelligence in the lifecycle of medicines

The EMA has opened a public consultation on a reflection paper presenting views . . .

Read More

Welcome Instem as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Instem as a new . . .

Read More

Regulatory Considerations Expert Group reviews draft FDA Guidance

The ACDM Regulatory Considerations Expert Group have reviewed and submitted comments on . . .

Read More

ICH GCP E6 Revision 3 is here. Regulatory Considerations Expert Group to review

The R&D industry, especially those that are working on clinical trials, have been . . .

Read More

Welcome Algorics as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Algorics as a . . .

Read More

Consultation response on legislative proposals for clinical trials

The MHRA have published the public consultation response to the proposals to reform the . . .

Read More

New MHRA Guidance

The MHRA have published new guidance on ‘Software and Artificial Intelligence (AI) as a . . .

Read More

FDA Guidance for Industry 

The FDA has issued a final guidance to provide information on risk-based approaches to . . .

Read More

Guideline on computerised systems and electronic data in clinical trials

The European Medicines Agency (EMA) have published the new guidelines on computerised . . .

Read More